Blue Horseshoe Stocks: FAST Recap & More

Fastenal, Inc. FAST

Our fresh options ideas for yesterday morning was regarding Fastenal,which had just posted a solid Q1 earnings beat. The potential targets that we highlighted were the FAST 04/18 $62.50-67.50 Calls, and we’re happy to report that the stock’s activity has allowed us to see some decent moves out of those so far, with five sessions remaining until their expiration.

The moves was observed yesterday were as follows:

$50 Calls – Range: 5.40-6.50 – Max Gain: 20%
$52.50 Calls – Range: 2.40-4.30  – Max Gain: 79%
$55 Calls – Range: 1.10-2.08 – Max Gain: 89%

With the markets heating up here in the premarket, we’ll want to continue to keep an eye on FAST for the possibility of further useful activity that could propel these contracts to more gains before their expiration next Thursday.
____

FRESH OPTIONS IDEAS:
The Walt Disney Co. DIS Weekly $122-125 Calls
SPDR S&P500 ETF (SPY) Weekly $289-290 Calls

*Don’t trade weekly options on a Friday unless you’re an advanced level trader with disposable funds!


Extended Watchlist:
BPTH, WPX, JCP, BSMX, CBAY, WPX, ENDP

Blue Horseshoe Stocks: NLNK Recap & More

NewLink Genetics Corp. NLNK

After our call of NLNK Thursday morning, the stock traded from 9.50-14.48 (+52%) which was a fantastic move for something it that price range.  We noted the strong close, and Friday morning re-iterated our interest despite the big move we’d already witnessed.

It’s a good thing we left NLNK on our radars, because while it didn’t quite rise to the previous session’s intraday performance, it came awfully close, and completed a very nice two-day swing for us in the process. Friday’s trading range on NLNK ran from 13.51 up to a new high of 19.30 for a daily move of 43% and representing a two-session rise of 103%

The stock traded thirteen times its monthly average volume, and maintained well over half its advance into a second consecutive strong close, so we’re quite curious to monitor its activity as we kick off a fresh trading week.


Kura Oncology Inc. KURA

Speaking of higher-priced movers, we also tagged KURA in Friday’s premarket report after the company’s mid-stage cancer treatment trials yielded positive results. It too went on a run which was uncharacteristically volatile for a $9+ stock.

The tradin grange on this one ran from 9.30-13.80 for an intraday push of 48% and did so on over 20X the monthly average volume. The close wasn’t quite as strong as the previously mentioned play, but we’ll still leave a slot open on our radar screens for KURA heading into this week.

______

Honorable Mention: Adaptimmune Therapeutics plc ADAP – While the level of gains provided wasn’t quite as high following our tag of ADAP on Thursday, the stock did string together a noteworthy couple of sessions. It traded from a low of 7.02 on Thursday to a high of 8.95 on Friday, marking a 27% swing.


Extended Watchlist:
MRNS, TEVA, BSMX, LINU, PETS